Quality of life of patients subjected to specific allergen immunotherapy
DOI:
https://doi.org/10.5604/01.3001.0010.7589Keywords:
allergy, allergens, specific immunotherapy, quality of lifeAbstract
Introduction: At present, allergic diseases are some of the most common chronic diseases affecting all spheres of human life. The only form of causative treatment of allergic diseases, apart from elimination of the sensitizing factor, is the specific allergen immunotherapy. The symptoms of allergic diseases can cause a number of consequences, including reduction of patient activity, negatively affect social relationships, ways of spending free time, and also cause sleep disorders. Assessing the quality of life in allergic diseases provides us with knowledge of the patient’s psychological and social functioning, and is a valuable addition to the review of the effectiveness of treatment for allergic diseases, allowing us to assess the patient’s overall well-being.
Aim of the study: The aim of the study was to evaluate the quality of life of patients using specific allergen immunotherapy.
Material and methods: 128 subjects were included in the study, but 100 questionnaires were used for the analysis. The study group was comprised of patients undergoing specific allergen immunotherapy over the age of 18 years. In this paper a diagnostic survey was used as a research method. The tools used are the standard questionnaire SF-36 and the questionnaire survey.
Results: In the present study, it was observed that the overall quality of life of people affected by allergic diseases, as measured by the SF-36 questionnaire, can be assessed as quite good. Respondents subjected to specific allergen immunotherapy consider this method of treatment positively influencing their health as they reduce the symptoms of allergies. As many as 91% of the respondents think that specific immunotherapy affects them to reduce the symptoms of allergies. It has also been shown that the length of therapy has no effect on reducing the symptoms of allergies.
Conclusions: The overall quality of life of patients is quite good, best evaluated in the domains of physical fitness, limitation of activity caused by emotional problems and changes in health status. Researchers positively evaluate the effect of immunotherapy on their health as it reduces the symptoms of allergies. Respondents have little knowledge about how to prevent exposure to allergens. Despite a positive assessment of the effectiveness of immunotherapy, the vast majority of respondents feel the need for additional antihistamines.
Downloads
References
Samoliński B., Raciborski F., Lipiec A. i wsp. Epidemiologia Chorób Alergicznych w Polsce (ECAP). Alergologia Polska – Pol J Allergology, 2014, 1(1), 10-18. Google Scholar
Ziętkowska E., Ziętkowski Z., Bodzenta-Łukaszyk A. Udział pielęgniarki w diagnostyce chorób alergicznych - testy skórne. Prob Pielęg, 2010, 18(4), 523-528. Google Scholar
Kruszewski J. Alergologia – postępy 2014. Med Prakt, 2015, 5(291), 67-73. Google Scholar
Pawliczak R. Alergologia kompendium. Wydawnictwo Medyczne Termedia, Poznań, 2013, 105-270. Google Scholar
Szczeklik A. Choroby wewnętrzne. Medycyna praktyczna, Kraków, 2006, 1813-1869. Google Scholar
Pietrzyk J.J. Vademecum pediatry. Wydawnictwo Uniwersytetu Jagiellońskiego, Kraków, 2011, 281-285. Google Scholar
Kucharczyk A., Faber K., Jahnz-Różyk K. Alergologia współczesna. 2005, 1(15), 34. Google Scholar
Kilanowicz M., Cegła B., Bartuzi Z. Czy jakość życia zależna od stanu zdrowia jest dobrym markerem badawczym w ocenie postępowania terapeutycznego w schorzeniach alergicznych?. Pielęg XXI w, 2006, 3(16), 97-101. Google Scholar
Kruszewski J., Nowicki R., Śpiewak R. Pokrzywki rozpoznanie i leczenie. Med Prakt, 2011, 87-88. Google Scholar
Cegła B. Ocena jakości życia pacjentów zainfekowanych bakterią Halicobacter pylori przed i po jej eradykacji. Praca doktorska, Collegium Medium, Bydgoszcz, 2005, 50. Google Scholar
Trojanowska A. Znaczenie badań nad jakością życia w medycynie. Zdrowie Publiczne, 2011,121(1), 99-103. Google Scholar
Jahnz-Różyk K. Problemy w alergologii: od teorii do praktyki. Wydanie jubileuszowe Alergologii współczesnej, Warszawa, 2011, 71-84. Google Scholar
Samoliński B. Epidemiologia alergii i astmy w Polsce — doniesienie wstępne badania ECAP. Terapia, 2008, 208, 127–131. Google Scholar
Kowalski M. Immunoterapia alergenowi. Wydawnictwo Mediton, Łódź, 2006, 11-149. Google Scholar
Hofman T. Immunoterapia całoroczna preparatem Allergovit, [Dostępne pod adresem: http://nexter.pl/alergologia_wspolczesna/index.php?action=6_2&rco=6] Google Scholar
Uchmanowicz I., Jankowska-Polańska B., Bronowicka A., i wsp. Determinanty jakości życia chorych na astmę oskrzelową, Nursing Topics, 2013, 21(4), 443–451. Google Scholar
Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol, 2000, 106(2), 253-259. Google Scholar
Hejjaoui A, Knani H, Dhivert F.B. et al. Duration of efficacy of specific immunotherapy with standardized mite extract after its cessation. J All Clin Immunol, 1992, 89, 319. Google Scholar
Farnik-Brodzińska M., Pierzchała W. Badania jakości życia jako ocena skuteczności leczenia chorób alergicznych. Alergologia współczesna, 2002, 10, 5-9. Google Scholar
Grevers G., Rocken M. Ilustrowany podręcznik chorób alergicznych. Wydawnictwo Urban&Partner, Wrocław, 2009, 43-121. Google Scholar
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 University of Applied Sciences in Tarnow, Poland & Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
